{"version":"1.0","type":"link","title":"Provider level facilitators and barriers towards neoadjuvant chemotherapy for triple negative and HER2 + breast cancer: a survey of Ontario surgeons.","author_name":"Ko G 외","author_url":"https://prs-insight.online/author/Ko%20G","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/76281","thumbnail_width":1200,"thumbnail_height":630}